| GTO ID | GTC3066 |
| Trial ID | NCT05414786 |
| Disease | HIV-1 Infection |
| Therapy | mRNA vaccine |
| Treatment | eOD-GT8 60mer mRNA Vaccine|mRNA-1644 |
| Phase | Phase1 |
| Recruitment status | Active, Not Recruiting |
| Title | A Phase 1 Study to Evaluate the Safety and Immunogenicity of eOD-GT8 60mer mRNA Vaccine (mRNA-1644) in HIV-1 Uninfected Adults in Good General Health |
| Year | 2022 |
| Country | Rwanda|South Africa |
| Company sponsor | International AIDS Vaccine Initiative |
| Other ID(s) | IAVI G003 |
| Cohort 1 | |||||||||
|
|||||||||